Gene and cell therapy as a new pillar of medicine
Interviewee/Contributor
Miguel Forte
Organisation
Bone Therapeutics SA
Research Directory
Pace of financing quickens for European biopharma
Interviewee/ContributorVictoria EnglishOrganisationMedNousImproving cardiac safety testing protocols
Interviewee/ContributorJohn RidleyOrganisationMetrion Biosciences LtdThe race to develop a COVID-19 vaccine
Interviewee/ContributorPeter CharlishOrganisationMedNousCoronavirus pandemic ushers in new collaborations
Interviewee/ContributorVictoria EnglishOrganisationMedNousReiThera rallies partners around candidate vaccine
Interviewee/ContributorAntonella FolgoriOrganisationReiThera SrlUnlocking the potential of PSMA as a cancer target
Interviewee/ContributorBrian McGuinness and Theodora HaroldOrganisationCrescendo Biologics LtdNew cancer drugs have unique mechanisms of action
Interviewee/ContributorBruno PagliaraOrganisationOncology specialist Bruno PagliaraLetter from Milano: The challenges facing biotech from the coronavirus
Interviewee/ContributorPierluigi ParacchiOrganisationGenenta Science SpAMechanism of immune disablement in HIV infection
Interviewee/ContributorJacques ThèzeOrganisationDiaccurate SAS